Ultra-low strut thickness of 50&mu;m for promoting early vascular healing
Variable strut width and variable crown design to ensure adequate radial strength of 1.1bar*
Hybrid cell stent design: Open cells in the middle of the stent for side-branch access and closed cell design on ends for optimal scaffolding and conformability
Clinically established drug everolimus with biodegradable polymer for proven clinical safety &amp; long term efficacy